Your browser doesn't support javascript.
loading
Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis.
Mehrotra, Siddharth; Hoppensteadt, Debra; Jeske, Walter; Siddiqui, Fakiha; Iqbal, Omer; Tafur, Alfonso; Lewis, Bruce; Jaradeh, Mark; Kantarcioglu, Bulent; Fareed, Jawed.
Afiliación
  • Mehrotra S; Department of Molecular Pharmacology & Neuroscience, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Hoppensteadt D; Department of Molecular Pharmacology & Neuroscience, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Jeske W; Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Siddiqui F; Department of Molecular Pharmacology & Neuroscience, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Iqbal O; Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Tafur A; Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Lewis B; Program in Health Sciences, 16728UCAM - Universidad Católica San Antonio de Murcia, Murcia, Spain.
  • Jaradeh M; Department of Molecular Pharmacology & Neuroscience, Cardiovascular Research Institute, 2456Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.
  • Kantarcioglu B; Department of Vascular Medicine, Northshore Cardiovascular Institute, NorthShore University Health Systems, Skokie, IL, USA.
  • Fareed J; Department of Internal Medicine, Division of Cardiology, 25815Loyola University Medical Center, Maywood, IL, USA.
Clin Appl Thromb Hemost ; 28: 10760296221138297, 2022.
Article en En | MEDLINE | ID: mdl-36476125

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rivaroxabán Límite: Humans Idioma: En Revista: Clin Appl Thromb Hemost Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rivaroxabán Límite: Humans Idioma: En Revista: Clin Appl Thromb Hemost Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos